glp 1 pen tirzepatida Lilly launches lower-price weight-loss drug Zepbound without injector Can a weight loss and

doi:10.1016/j.str.2021.04.001 85

CT-388 was designed to have potent activity on both the GLP-1 and GIP receptors but with minimal to no -arrestin recruitment on either receptor

GLP-1 drugs also influence the release of hormones that regulate sleep and wakefulness

Luo ZY, Li X, Chen CT, et al

However, beyond the efficacy for metabolic control, the current guidelines of diabetes mellitus pharmacotherapy are directed towards protection in the cardiovascular health and other complications, for which this pharmacological group is positioned as an important option, demonstrating a reduction of cardiovascular events compared to placebo which may be comparable to recent result from SGLT-2 inhibitors